The consumer-genomics company 23andMe just sold its biobank of customer genetic data to drugmaker Regeneron for $256 million.

Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.

  • slaneesh_is_right@lemmy.orgEnglish
    3·
    6 hours ago

    If i would look for my parents or a lost sibling or whatever, i wouldn’t care, take my data i guess. But everyone knows that almost everyone who took that test did it for attention and because it was the cool thing influencers did.